FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

418747006: Hepatitis B surface antigen immunoglobulin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3782556017 Hepatitis B surface antigen immunoglobulin (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
3782557014 Hepatitis B surface antigen immunoglobulin en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
15731000188114 immunoglobulines humaines anti-hépatite B fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
299091000077113 immunoglobuline contre l'antigène de surface de l'hépatite B fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hepatitis B surface antigen immunoglobulin (substance) Is a Immunoglobulin false Inferred relationship Some
Hepatitis B surface antigen immunoglobulin (substance) Is a Human immunoglobulin (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Hepatitis B immunoglobulin adverse reaction Causative agent (attribute) True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B immunoglobulin allergy Causative agent (attribute) False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
poudre de 1000 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
poudre de 200 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
poudre de 500 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
Hepatitis B surface antigen immunoglobulin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Anti-hbs immunoglobulin injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
flacon de 1 unité d'immunoglobuline contre l'hépatite B The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
flacon d'une solution injectable de 217 U d'immunoglobuline antihépatique B The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
flacon de 1 mL d'une solution injectable de 312 unités/mL d'immunoglobuline contre l'hépatite B The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
flacon de 5 mL d'une solution injectable de 312 unités/mL d'immunoglobuline contre l'hépatite B The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some
Hepatitis B immunoglobulin allergy Causative agent (attribute) False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing only Hepatitis B surface antigen immunoglobulin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Allergy to Hepatitis b surface antigen immunoglobulin Causative agent (attribute) True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B surface antigen immunoglobulin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
poudre de 200 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
poudre de 500 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B surface antigen immunoglobulin 50 unit/mL solution for infusion and/or injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1
Hepatitis B surface antigen immunoglobulin 50 unit/mL solution for infusion and/or injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hepatitis B surface antigen immunoglobulin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start